Novo Nordisk A/S (NONOF)

Novo Nordisk Revenue

Novo Nordisk had revenue of 71.31B DKK in the quarter ending September 30, 2024, with 21.42% growth. This brings the company's revenue in the last twelve months to 270.58B, up 26.15% year-over-year. In the year 2023, Novo Nordisk had annual revenue of 232.26B with 31.26% growth.

• Revenue (ttm): 270.58B DKK
• Revenue Growth: +26.15%
• P/S Ratio: n/a
• Revenue / Employee: 4.21M DKK
• Employees: 64,319
• Market Cap: 451.00B USD

Revenue Chart

* This company reports financials in DKK.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	232.26B	55.31B	31.26%
Dec 31, 2022	176.95B	36.15B	25.68%
Dec 31, 2021	140.80B	13.85B	10.91%
Dec 31, 2020	126.95B	4.93B	4.04%
Dec 31, 2019	122.02B	10.19B	9.11%